Our Alkalizator and PATfix products are now available with flexible leasing options, reflecting the significant interest and demand from our global customers. These options provide a cost-effective solution without the need for CAPEX so that you can start benefiting from these technologies immediately.
Key Benefits:
- Cost-Effective Acquisition: Access cutting-edge technology without the upfront capital expenditure, ideal for optimizing budget allocations.
- Operational Flexibility: Streamline your bioprocessing operations with single-use, high-performance solutions tailored for large biomolecules.
- Global Accessibility: Designed to meet the needs of our diverse international clientele, ensuring reliable and efficient bioprocessing.
- Convenient Leasing Process: Our sales team is ready to assist with quotes and facilitate leasing offers through our trusted banking partners
Matevž Korenč, the Product Manager for Alkalizator, provided valuable insights regarding this decision: “We often see clients who are eager to implement the Alkalizator to streamline their lysis steps but get stuck in lengthy capital expenditure approval cycles. Introducing leasing is our way of saying: ‘We hear you.’ We want to remove those administrative barriers so you can focus on what matters—optimizing your process immediately.”
Marko Šnajder, the Product Manager for PATfix, concurred: “I know CAPEX is tight for many teams right now. The good news is that you can bring PATfix online with a simple lease—no upfront capital, just a predictable monthly cost. You get high-performance analytics for large biomolecules immediately, and we can tailor the solutions for your success.“
If you’re interested in learning more about these leasing options, please contact sales@biaseparations.com.
